Edoxaban Safe, Effective in Kids With Heart Disease: ENNOBLE-ATE
Medscape,
Treatment with the direct factor Xa inhibitor edoxaban (Lixiana) resulted in low rates of clinically relevant bleeding and…
Treatment with the direct factor Xa inhibitor edoxaban (Lixiana) resulted in low rates of clinically relevant bleeding and…
Halving the duration of therapy is noninferior to the standard 3 months in patients younger than 21, the Kids-DOTT trial shows.
The decision makes dabigatran the first oral drug approved for this indication, following 5 days of parenteral anticoagulants.
Cardiology > Prevention Easier way to treat venous thromboembolism now available The FDA approved the first direct oral…